JCO clinical cancer informaticsHumansFemaleBreast NeoplasmsMiddle AgedFeasibility Studies
Feasibility of a Smart Label-Enabled Remote Therapeutic Monitoring Intervention to Support Cyclin-Dependent Kinase 4/6 Inhibitor Adherence in Breast Cancer Care.
Ilana Graetz, Sara Arshad, Clara Cai, Samuel Hernandez, Tamar Sapir, Jeffrey Carter, Cherilyn Heggen, Kelly E McKinnon, Freddie Yang, Gelareh Sadigh, Jane Meisel
Published: 202510.1200/CCI-25-00152
Abstract
PURPOSE: Cyclin-dependent kinase 4 and 6 inhibitors (CDKIs) are effective breast cancer therapies but pose adherence challenges because of cost, side effects, and complexity of medication schedule. We assessed the feasibility and usability of a smart…
Preview only. Read the full abstract at the source